bioRxiv Science⌕ Search

Biology subjects

Qiao, R.

Publications and source records attributed to Qiao, R..

20 records · Page 2Linked to original sources

ARIC: Accurate and robust inference of cell type proportions from bulk gene expression or DNA methylation data

Quantifying the cell proportions, especially for rare cell types in some scenarios, is of great value to track signals related to certain phenotypes or diseases. Although some methods have been pro-posed to infer cell proportions from multi-component bulk data, they are substantially less effective for estimating rare cell type proportions since they are highly sensitive against feature outliers and collinearity. Here we proposed a new deconvolution algorithm named ARIC to estimate cell type proportions from bulk gene expression or DNA methylation data. ARIC utilizes a novel two-step marker selection strategy, including component-wise condition number-based feature collinearity elimination and adaptive outlier markers removal. This strategy can systematically obtain effective markers that ensure a robust and precise weighted {upsilon}-support vector regression-based proportion prediction. We showed that ARIC can estimate fractions accurately in both DNA methylation and gene expression data from different experiments. Taken together, ARIC is a promising tool to solve the deconvolution problem of bulk data where rare components are of vital importance.

bioinformatics↗

Identifying neoantigens for cancer vaccines by personalized deep learning of individual immunopeptidomes

Tumor-specific neoantigens play the main role for developing personal vaccines in cancer immunotherapy. We propose, for the first time, a personalized de novo sequencing workflow to identify HLA-I and HLA-II neoantigens directly and solely from mass spectrometry data. Our workflow trains a personal deep learning model on the immunopeptidome of an individual patient and then uses it to predict mutated neoantigens of that patient. This personalized learning and mass spectrometry-based approach enables comprehensive and accurate identification of neoantigens. We applied the workflow to datasets of five melanoma patients and substantially improved the accuracy and identification rate of de novo HLA peptides by 14.3% and 38.9%, respectively. This subsequently led to the identification of 10,440 HLA-I and 1,585 HLA-II new peptides that were not presented in existing databases. Most importantly, our workflow successfully discovered 17 neoantigens of both HLA-I and HLA-II, including those with validated T cell responses and those novel neoantigens that had not been reported in previous studies.

bioinformatics↗